16th and 17th of September 2021
Ramada Lisbon Hotel
FRAMEWORK
In the past few years, the medical cannabis industry has experienced exponential growth with the legalization to sell and consume medicinal cannabis products, in several countries in Europe. The increasing demand for these products and the profit margins associated, led several investors to invest in the medicinal cannabis market. According to several analysts, this market size has the potential to reach 3.2 billion euros by the end of 2025.
In this context, the medical cannabis industry, as well as all involved stakeholders are facing the main challenge of interpretation and be compliance with EU-GACP and EU-GMP regulations to be able to place cannabis-based products for medicinal purposes on the market demonstrating consistency, quality, efficacy and patient safety.
These are the mandatory assumptions for health authorities and patients’ confidence in the medical cannabis industry, which will lead to the development of this market in Portugal.
PURPOSE
The Medical Cannabis Europe Conference was specially developed to debate and clarify doubts regarding the applicable regulations to the cultivation, manufacture and distribution of cannabis-based products for medicinal purposes in Portugal and Europe. This conference will feature international and local experts on medical cannabis that will provide insights into the European market and address aspects such as applicable regulations and expectations of the authority in licensing inspections.
PURPOSE
The Medical Cannabis Europe Conference was specially developed to argument and clarify doubts regarding the regulations applicable to the cultivation, manufacture and distribution of cannabis-based for medicinal purposes in Portugal and Europe. This conference will feature international and local experts on medical cannabis that will provide insights into the European market and address aspects such as applicable regulations and expectations of the authority in licensing inspections.
Program
Day 16
Program
Conference Opening Session
Medicinal Cannabis Legislation Framework & Licensing and Submission – Pre-license to License
Speakers: Eduardo Nogueira Pinto and Pedro Lomba, PLMJ
Medicinal Cannabis – A European Market Overview
Speakers: Lukas Röth and Tobias Viegener, CSCLife
Route from GACP to GMP
Speakers:
Nuno Santos, Stepwise Pharma & Engineering;
Miguel Fagundes, Botanical Holdings Plc.
GDP for Medicinal Cannabis
Speaker: Hugo Barbosa, Rangel Pharma
Quality System for Medicinal Cannabis
Speaker: Fátima Carvalho, LEF
Commissioning, Qualification & Validation
Speaker: Aldo Vidinha, Stepwise Pharma & Engineering
Traceability of Medical Cannabis Products
Speaker: Rob Perry, GrowerlQ
Wine & Cheese Moment
The conference will be fully in English language.
Day 17
Program
Conference Opening Session
Quality Control for Medicinal Cannabis
Orador: Ana Brízio e Sara Figueiredo, LEF
Medicinal Cannabis Security Measures – is there a standardization?
Speaker: Sérgio Bagulho, TAP | ANF
Regulatory Requirements for Market Entry in Portugal
Speaker: Cristina Toscano, LEF
Regulatory Requirements for Market Entry in Israel
Speaker: Amit Edri, Portocanna
Regulatory Requirements for Market Entry in Uruguay
Speaker: Carlos Lacava, FIP
Audits and Inspections: Sharing Experiences
Speakers:
Graça Flores, Clever Leaves;
Miguel Fagundes, Botanical Holdings Plc;
Vera Broder, Medicane
Moderator:
Maria Jorge Costa, ANF
Open Discussion: Q&A
Place
Ramada Lisbon Hotel, Portugal
Format
Face-to-face*
Price
Daily Ticket 650€ (day 16 or 17)
Normal Ticket 2 Days: 980€
Includes
Lunch for 2 days, coffee break and Wine & Cheese Moment
* If, on the date of the conference, there are restrictions to face-to-face events, the virtual format will be adopted.
ATTENDEES
The conference is orientated to all entities involved in the medical cannabis industry, from:
Investors, growers, holders of pharmaceutical manufacture licenses, manufacturers, suppliers, importers / exporters, technical directors and quality technicians and ever health authority inspectors.
ATTENDEES
The conference is orientated to all entities involved in the medical cannabis industry, from:
Investors, growers, manufacturers, suppliers, importers / exporters, wholesalers, Qualified Person, QA/QP technicians and even health authority inspectors.
SPEAKERS
Aldo Vidinha
CEO of Stepwise Chemical Engineer Medicinal Cannabis Expert
Ana Brízio
Quality Control Manager and Qualified Person at LEF
Eduardo Nogueira Pinto
Partner and Head of the Healthcare, Life Sciences & Pharmaceuticals Practice at PLMJ | Lawyer
Fátima Godinho Carvalho
Technical Director and Executive Director at LEF | Pharmacist
Graça Flores
Head of Compliance at Clever Leaves | Chemical Engineer
Hugo Barbosa
Technical Director and Quality Assurance at Rangel | Pharmacist
Lukas Röth
Co-Founder of CSCLife | Freelance Consultant
Pedro Lomba
Partner and Head of the Technology, Mobility and Communications at PLMJ | Professor | Lawyer
Tobias Viegener
Co-Founder of CSCLife
Sérgio Bagulho
Security Manager
Nuno Santos
Pharma Business Unit Manager at Stepwise Pharma & Engineering
Amit Edri
Co-Founder and CEO of Portocanna
Vera Broder
CEO Portugal of Medicane Health Incorporated
Miguel Fagundes
Chief Technical Officer & QP at Botanical Holdings Plc.
Rob Perry
Vice President Sales, GrowerIQ
Cristina Toscano
Regulatory Affairs Manager | QPPV | Pharmacist
Carlos Lacava
Coordinator National Medical Cannabis Programme | Ministry of Public Health | Pharmacist
Sara Figueiredo
Quality Control Supervisor at LEF
Day(s)
:
Hour(s)
:
Minute(s)
:
Second(s)
REGISTRATIONS
ORGANIZERS
Patrocinadores
Botanical Holdings
Platinium Sponsor
Merck
Gold Sponsor
Instadose Pharma
Silver Sponsor
Technoedif Engenharia
Silver Sponsor
Novagric
Silver Sponsor
Agro Technology’s
Stand Pack Sponsor
Modus Complete
Stand Pack Sponsor
Ibet
Stand Pack Sponsor
Media Partners
English 
Portuguese